D 69 (Didanosine Delayed Release 200 mg)
Pill with imprint D 69 is White, Capsule-shape and has been identified as Didanosine Delayed Release 200 mg. It is supplied by Aurobindo Pharma.
Didanosine is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Didanosine 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for D 69
Didanosine Delayed Release
- Imprint
- D 69
- Strength
- 200 mg
- Color
- White
- Size
- 19.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Aurobindo Pharma
- National Drug Code (NDC)
- 65862-0311 (Discontinued)
- Inactive Ingredients
-
sodium starch glycolate type A potato,
carboxymethylcellulose sodium,
sodium lauryl sulfate,
hypromellose 2910 (3 mPa.s),
magnesium silicate,
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
diethyl phthalate,
silicon dioxide,
gelatin,
titanium dioxide,
ferrosoferric oxide,
shellac
Note: Inactive ingredients may vary.
Related images for "D 69"
More about didanosine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Drug images
- En español
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
